420 related articles for article (PubMed ID: 35008680)
1. Histone Modifications and Their Targeting in Lymphoid Malignancies.
Fernández-Serrano M; Winkler R; Santos JC; Le Pannérer MM; Buschbeck M; Roué G
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008680
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
4. Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.
Markouli M; Strepkos D; Piperi C
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362442
[TBL] [Abstract][Full Text] [Related]
5. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
7. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
Komar D; Juszczynski P
Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic targeting for acute kidney injury.
Zhuang S
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():21-25. PubMed ID: 30298650
[TBL] [Abstract][Full Text] [Related]
9. Targeting epigenetic DNA and histone modifications to treat kidney disease.
Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
[TBL] [Abstract][Full Text] [Related]
10. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
[TBL] [Abstract][Full Text] [Related]
11. Aberrant epigenetic gene regulation in lymphoid malignancies.
Taylor KH; Briley A; Wang Z; Cheng J; Shi H; Caldwell CW
Semin Hematol; 2013 Jan; 50(1):38-47. PubMed ID: 23507482
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications.
Vegliante MC; Royo C; Palomero J; Salaverria I; Balint B; Martín-Guerrero I; Agirre X; Lujambio A; Richter J; Xargay-Torrent S; Bea S; Hernandez L; Enjuanes A; Calasanz MJ; Rosenwald A; Ott G; Roman-Gomez J; Prosper F; Esteller M; Jares P; Siebert R; Campo E; Martín-Subero JI; Amador V
PLoS One; 2011; 6(6):e21382. PubMed ID: 21738649
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of lymphomas in the era of epigenetics.
Chebly A; Chouery E; Ropio J; Kourie HR; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Blood Rev; 2021 Jul; 48():100782. PubMed ID: 33229141
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
15. Targeting Histone Onco- Modifications Using Plant-Derived Products.
Illam SP; Kandiyil SP; Raghavamenon AC
Curr Drug Targets; 2021; 22(11):1317-1331. PubMed ID: 33461463
[TBL] [Abstract][Full Text] [Related]
16. Cancers with wrong HATs: the impact of acetylation.
Di Cerbo V; Schneider R
Brief Funct Genomics; 2013 May; 12(3):231-43. PubMed ID: 23325510
[TBL] [Abstract][Full Text] [Related]
17. Somatic alterations and dysregulation of epigenetic modifiers in cancers.
Aumann S; Abdel-Wahab O
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):24-34. PubMed ID: 25111821
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
19. Chromatin-Remodeled State in Lymphoma.
Liu Y; Gonzalez Y; Amengual JE
Curr Hematol Malig Rep; 2019 Oct; 14(5):439-450. PubMed ID: 31489524
[TBL] [Abstract][Full Text] [Related]
20. Histone Deacetylase Inhibitors as Anticancer Drugs.
Eckschlager T; Plch J; Stiborova M; Hrabeta J
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
